Our Gilead stock price prediction shows gains ahead, even after Gilead Sciences Inc. (Nasdaq: GILD) shares have fallen more than 7% since the...
Sometimes Washington triggers a stock move that can hand us outsized gains. That's exactly what happened with Gilead Sciences Inc. (Nasdaq: GILD)....
Gilead Sciences Inc. (Nasdaq: GILD) is facing criticism again this week for its highly priced Hepatitis C drug Sovaldi. The...
In my 30 years knocking around Silicon Valley, I've found that the stocks with the best charts tend to be small caps.
But my charts...
One of the reasons biotech stocks can be your portfolio’s biggest winners is because of the massive profits companies see after releasing a...
Since April 11, Gilead Sciences (Nasdaq: GILD) has scored peak gains of a 74.2% - or more than 175% annualized...
Gilead Sciences Inc. (Nasdaq: GILD) stock hit a 52-week high of $92.97 this morning (Thursday) after the company crushed...
Late last month, I told you that biotech is one of the best ways to profit from the tech rebound.
Somewhat ironically, a rollover in ...
The American Society of Clinical Oncology meets every spring. It's attended by some 30,000 people and hosts 4,000...
The year is nearly half over, and the mainstream media continues to obsess over a whipsaw stock market that's been cutting highflyers down to...
